Lubiprostone
NDC 63304-351, lubiprostone, capsule, gelatin coated, from Sun Pharmaceutical Industries, Inc..
- Product NDC
- 63304-351
- Status
- Listed
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Dosage form
- CAPSULE, GELATIN COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA021908
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63304-351 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LUBIPROSTONE8 ug/1
Pharmacologic classes
Chloride Channel Activator [EPC]; Chloride Channel Activators [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63304-351-60 | 63304035160 | 60 CAPSULE, GELATIN COATED in 1 BOTTLE (63304-351-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f06d76d2-028a-629f-e053-2995a90a80f5NADAC price for package 63304035160
GET /v1/drugs/nadac/63304035160
Use it
Look up 63304-351 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63304-351 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63304-351. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.